← Back to Search

Metronidazole for Crohn's Disease

Phase 4
Waitlist Available
Led By Sandra Kavalukas, MD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
20-80 years old who is deemed an acceptable surgical candidate for ileocolic resection.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six months
Awards & highlights

Study Summary

This trial will compare two types of post-operative treatment for Crohn's disease.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in bacteria in the gut

Trial Design

2Treatment groups
Active Control
Group I: Standard careActive Control1 Intervention
Standard post-operative care, which may or may not include post-operative antibiotics
Group II: MetronidazoleActive Control1 Intervention
Metronidazole 250 mg three times a day

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
338 Previous Clinical Trials
75,976 Total Patients Enrolled
Sandra Kavalukas, MDPrincipal InvestigatorUniversity of Louisville

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025